Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 2
2016 5
2018 2
2019 1
2020 5
2021 4
2022 6
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Extracellular vesicles in anti-tumor immunity.
Vergani E, Daveri E, Vallacchi V, Bergamaschi L, Lalli L, Castelli C, Rodolfo M, Rivoltini L, Huber V. Vergani E, et al. Semin Cancer Biol. 2022 Nov;86(Pt 1):64-79. doi: 10.1016/j.semcancer.2021.09.004. Epub 2021 Sep 9. Semin Cancer Biol. 2022. PMID: 34509614 Free article. Review.
microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.
Daveri E, Vergani E, Shahaj E, Bergamaschi L, La Magra S, Dosi M, Castelli C, Rodolfo M, Rivoltini L, Vallacchi V, Huber V. Daveri E, et al. Among authors: vergani e. Front Immunol. 2020 Jul 22;11:1214. doi: 10.3389/fimmu.2020.01214. eCollection 2020. Front Immunol. 2020. PMID: 32793185 Free PMC article. Review.
3D models for melanoma γδ T cell-based immunotherapy.
Huber V, Vallacchi V, Daveri E, Vergani E. Huber V, et al. Among authors: vergani e. Clin Transl Med. 2022 Jun;12(6):e926. doi: 10.1002/ctm2.926. Clin Transl Med. 2022. PMID: 35696610 Free PMC article. No abstract available.
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.
Camisaschi C, Vallacchi V, Vergani E, Tazzari M, Ferro S, Tuccitto A, Kuchuk O, Shahaj E, Sulsenti R, Castelli C, Rodolfo M, Rivoltini L, Huber V. Camisaschi C, et al. Among authors: vergani e. Vaccines (Basel). 2016 Nov 4;4(4):38. doi: 10.3390/vaccines4040038. Vaccines (Basel). 2016. PMID: 27827921 Free PMC article. Review.
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles.
Vergani E, Busico A, Dugo M, Devecchi A, Valeri B, Cossa M, Di Guardo L, De Cecco L, Feltrin E, Valle G, Deho P, Frigerio S, Lalli L, Gallino G, Del Vecchio M, Santinami M, Pruneri G, Tamborini E, Rivoltini L, Sensi M, Vallacchi V, Rodolfo M. Vergani E, et al. J Invest Dermatol. 2022 Nov;142(11):3030-3040.e5. doi: 10.1016/j.jid.2022.04.027. Epub 2022 May 26. J Invest Dermatol. 2022. PMID: 35643181 Free article.
Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma.
Patel A, Garcia LF, Mannella V, Gammon L, Borg TM, Maffucci T, Scatolini M, Chiorino G, Vergani E, Rodolfo M, Maurichi A, Posch C, Matin RN, Harwood CA, Bergamaschi D. Patel A, et al. Among authors: vergani e. Cancer Res. 2020 Jun 15;80(12):2676-2688. doi: 10.1158/0008-5472.CAN-19-3230. Epub 2020 Apr 14. Cancer Res. 2020. PMID: 32291316
27 results